About SmartHealth
SmartHealth is a Healthcare company based in Irvine (United States) founded in 1979. Precision diagnostics for vascular, metabolic, and oncological diseases are developed. SmartHealth has raised $17.29 million across 3 funding rounds. Its chief executive, as recorded, is Larry Dentice. SmartHealth offers products and services including MUSE Technology, SmartVascular Dx, and SmartKidney Dx. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its competitors include Guardant Health, Natera and Foundation Medicine; 3 of its 3 listed competitors have raised funding.
Company details
SmartHealth was founded in 1979 in Irvine, United States, within the healthcare diagnostics sector. Precision tests such as SmartPath Dx and SmartVascular Dx are provided for vascular inflammation and pathology detection. Additional offerings include SmartLung Dx for lung cancer identification and SmartKidney Dx for kidney disease assessment. Operations center on advancing diagnostic tools for metabolic and oncological conditions across clinical applications.
- Headquarters Irvine, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website smarthealthdx.com
- Social LinkedIn X Facebook Instagram
- Total Equity Funding$17.29M (USD)
in 3 rounds
- Latest Funding Round$300K (USD), Series B
Nov 2024
Products & Services of SmartHealth
SmartHealth offers a comprehensive portfolio of products and services, including MUSE Technology, SmartVascular Dx, and SmartKidney Dx.
Provides slide-free imaging for rapid and precise diagnostics.
Detects inflammation to enhance vascular health monitoring.
Identifies Renal Cell Carcinoma for timely cancer treatment.
Funding Insights of SmartHealth
SmartHealth has successfully raised a total of $17.29M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $300 thousand completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.29M
- Total Rounds 3
- Last Round Series B — $300,000
- First Round $15.59M
(Mar 2023)
All 3 funding rounds of SmartHealth with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2024 | $300,000 | Series B | – | – | – |
| Aug 2024 | $1.4M | Series B | – | – | – |
| Mar 2023 | $15.59M | Series B | – | – | – |
People of SmartHealth
2 people are tracked at SmartHealth (2 in leadership).
| Name | Role | Group |
|---|---|---|
Larry Dentice | CEO | Leadership |
Matthew Nunez | CEO | Leadership |
Complete people profiles for SmartHealth
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of SmartHealth
3 dated milestones of SmartHealth across 45 years, from founding to its latest funding, stage changes and deals.
- Founded SmartHealth is founded.
- Funding First funding round of $15.6M.
- Funding Latest funding round, Series B, of $300K.
Competitors of SmartHealth
SmartHealth has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Natera and Foundation Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| guardanthealth.com | 2012 | Redwood, United States | $557.5M | 1,351 | Digital sequencing technology for cancer detection is developed. | |
| natera.com | 2004 | Redwood, United States | $152.1M | 3,293 | Developer of cell-free DNA testing for oncology, women’s health, and organ health | |
| foundationmedicine.com | 2010 | Cambridge, United States | $96.5M | 1,707 | Genomics-based diagnostic tests for cancer are provided. |
Detailed competitors of SmartHealth
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of SmartHealth
The website of SmartHealth (smarthealthdx.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▲ 103.8% vs previous month
Top companies in Immunology & Cancer Therapeutics
3 companies that operate in the same segment as SmartHealth (Immunology & Cancer Therapeutics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Targeted and immune-oncology drugs for cancer treatment are developed. | 2010 | Cambridge, Massachusetts, United States | USD 172 M | |||
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed. | 2013 | San Francisco, California, United States | USD 214.78 M | USD 21.05 M | 211 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Smarthealth
Complete news archive for SmartHealth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SmartHealth
SmartHealth was founded in 1979 and raised its 1st funding round 44 years after it was founded.
SmartHealth is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Larry Dentice is the CEO of SmartHealth, as recorded in our data.
SmartHealth is a funded company, having raised a total of $17.29M across 3 funding rounds to date. The company's 1st funding round was a Series B of $15.59M, raised on Mar 2023.
SmartHealth was founded in 1979 in Irvine, United States, within the healthcare diagnostics sector. Precision tests such as SmartPath Dx and SmartVascular Dx are provided for vascular inflammation and pathology detection. Additional offerings include SmartLung Dx for lung cancer identification and SmartKidney Dx for kidney disease assessment. Operations center on advancing diagnostic tools for metabolic and oncological conditions across clinical applications.
SmartHealth's top competitors include Guardant Health, Foundation Medicine and Natera.
SmartHealth offers MUSE Technology, SmartVascular Dx, and SmartKidney Dx.